Bone health of transgender adults: what the radiologist needs to know.
Justin T StowellHillary W GarnerStephen HerrmannKimberly TilsonRupert O StanboroughPublished in: Skeletal radiology (2020)
Sex steroids are important regulators of bone development before puberty and of bone homeostasis throughout adulthood. Gender-affirming therapies with sex steroids are used in transgender and gender diverse persons for treatment of gender dysphoria, which may have profound impacts on their bone metabolism. Many studies have described variable changes in bone density and geometry in transgender cohorts. In order to provide informed guidance on the effect of gender-affirming therapy, the International Society of Clinical Densitometry issued official position statements in 2019 for the performance and interpretation of dual-energy x-ray absorptiometry in transgender and gender-diverse patients. We review the effects of gender-affirming hormone therapy on bone physiology and the changes in bone modulation that have been reported in the literature in transgender patients who have received gender-affirming therapy. We also summarize the recent guidelines for interpretation of dual energy x-ray absorptiometry as an update for the radiologist.
Keyphrases
- dual energy
- bone mineral density
- computed tomography
- mental health
- end stage renal disease
- postmenopausal women
- soft tissue
- bone loss
- bone regeneration
- chronic kidney disease
- ejection fraction
- newly diagnosed
- public health
- healthcare
- peritoneal dialysis
- stem cells
- hiv testing
- magnetic resonance imaging
- depressive symptoms
- risk assessment
- contrast enhanced
- high resolution
- autism spectrum disorder
- bone marrow
- clinical practice
- mass spectrometry
- hiv infected
- climate change
- intellectual disability
- antiretroviral therapy
- human health
- early life